taurine has been researched along with Bacterial Disease in 21 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study shows that catheter filling with a solution containing the antimicrobial taurolidine may significantly reduce the incidence of catheter-related sepsis." | 9.11 | Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. ( Betjes, MG; van Agteren, M, 2004) |
| "As secondary peritonitis is associated with a significant cytokine release that is compartementalized in the peritoneal cavity, taurolidine is bactericidal, antiendotoxic, and antiadherent locally and, on the other hand, may modulate the systemic cytokine-mediated inflammatory response after being adsorbed systemically by the peritoneum." | 6.40 | [Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation]. ( Staubach, KH, 1997) |
| "This study shows that catheter filling with a solution containing the antimicrobial taurolidine may significantly reduce the incidence of catheter-related sepsis." | 5.11 | Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. ( Betjes, MG; van Agteren, M, 2004) |
| "Taurolidine has demonstrated inhibition of biofilm formation in vitro." | 2.77 | Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin. ( Funch, P; Fuursted, K; Handrup, MM; Møller, JK; Schrøder, H, 2012) |
| "As secondary peritonitis is associated with a significant cytokine release that is compartementalized in the peritoneal cavity, taurolidine is bactericidal, antiendotoxic, and antiadherent locally and, on the other hand, may modulate the systemic cytokine-mediated inflammatory response after being adsorbed systemically by the peritoneum." | 2.40 | [Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation]. ( Staubach, KH, 1997) |
| "Taurolidine is an anti-infective agent with an unusually broad spectrum of effectivity against gram-positive and gram-negative bacteria, anaerobic organisms, and fungi." | 1.30 | [The influence of taurolidine on physiological and pathological blood coagulation and implications for its use]. ( Reinmüller, J, 1999) |
| " However, by increasing the dosage of taurolin, survival is prolonged and mortality reduced." | 1.26 | The in vitro and in vivo activity of taurolin against anaerobic pathogenic organisms. ( Brodhage, H; Browne, MK; Leslie, GB; Pfirrman, RW, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (28.57) | 18.7374 |
| 1990's | 10 (47.62) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Stacy, A | 1 |
| Andrade-Oliveira, V | 1 |
| McCulloch, JA | 1 |
| Hild, B | 1 |
| Oh, JH | 1 |
| Perez-Chaparro, PJ | 1 |
| Sim, CK | 1 |
| Lim, AI | 1 |
| Link, VM | 1 |
| Enamorado, M | 1 |
| Trinchieri, G | 1 |
| Segre, JA | 1 |
| Rehermann, B | 1 |
| Belkaid, Y | 1 |
| Weber, M | 1 |
| Meyer, F | 1 |
| Halloul, Z | 1 |
| Handrup, MM | 1 |
| Fuursted, K | 1 |
| Funch, P | 1 |
| Møller, JK | 1 |
| Schrøder, H | 1 |
| Betjes, MG | 1 |
| van Agteren, M | 1 |
| Nentwig, GH | 1 |
| Kniha, H | 1 |
| Linder, MM | 1 |
| Ott, W | 1 |
| Wesch, G | 1 |
| Reding, R | 1 |
| Pfirrman, RW | 2 |
| Reisser, C | 1 |
| Mielenz, H | 1 |
| Jünemann, K | 1 |
| Zimmermann, M | 2 |
| Preac-Mursic, V | 1 |
| Popović, M | 1 |
| Dugalni, D | 1 |
| Milićević, M | 1 |
| Petrović, M | 1 |
| Zuvela, M | 1 |
| Knezević, S | 1 |
| Janković, Z | 1 |
| Focht, J | 1 |
| Nösner, K | 1 |
| Staubach, KH | 1 |
| Reinmüller, J | 1 |
| Shah, CB | 1 |
| Mittelman, MW | 1 |
| Costerton, JW | 1 |
| Parenteau, S | 1 |
| Pelak, M | 1 |
| Arsenault, R | 1 |
| Mermel, LA | 1 |
| Browne, MK | 3 |
| Leslie, GB | 1 |
| Brodhage, H | 1 |
| MacKenzie, M | 1 |
| Doyle, PJ | 1 |
| Billing, A | 1 |
| Fröhlich, D | 1 |
| Ruckdeschel, G | 1 |
| Burri, C | 1 |
| Kalas, L | 1 |
| Kárpáti, V | 1 |
| McCartney, AC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non[NCT02279121] | 162 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| A Randomised Study of Taurolock for the Locking of Tunneled Central Venous Catheters in Children With Malignant Diseases.[NCT00735813] | Phase 3 | 129 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for taurine and Bacterial Disease
| Article | Year |
|---|---|
[Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation].
Topics: Anti-Infective Agents; Bacterial Infections; Combined Modality Therapy; Cytokines; Humans; Peritonit | 1997 |
[Treatment of local infection with taurolin].
Topics: Anti-Infective Agents, Local; Bacterial Infections; Chronic Disease; Fracture Fixation, Internal; Ge | 1990 |
6 trials available for taurine and Bacterial Disease
| Article | Year |
|---|---|
Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
Topics: Adolescent; Anti-Bacterial Agents; Anticoagulants; Antineoplastic Agents; Bacterial Infections; Biof | 2012 |
Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Topics: Anti-Infective Agents; Bacterial Infections; Catheterization, Central Venous; Catheters, Indwelling; | 2004 |
Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Topics: Anti-Infective Agents; Bacterial Infections; Catheterization, Central Venous; Catheters, Indwelling; | 2004 |
Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Topics: Anti-Infective Agents; Bacterial Infections; Catheterization, Central Venous; Catheters, Indwelling; | 2004 |
Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Topics: Anti-Infective Agents; Bacterial Infections; Catheterization, Central Venous; Catheters, Indwelling; | 2004 |
[Antibacterial therapy of purulent peritonitis: a prospective randomized study on the effects of antibiotics and taurolin, a new chemotherapeutic and antiendotoxic agent (author's transl)].
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Endotoxins; Female; Humans; | 1980 |
C controlled trial of taurolin in established bacterial peritonitis.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Local; Bacterial Infections; Child; Clinical Trials | 1978 |
[Treatment of orofacial infections. Taurolidine--an alternative treatment concept to antimicrobial chemotherapy].
Topics: Administration, Topical; Anti-Infective Agents, Local; Bacterial Infections; Humans; Mouth Diseases; | 1992 |
Clinical studies on administration of taurolin in severe sepsis: a preliminary study.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Clinical Trials as Topic; Endotoxins; Female; Hum | 1988 |
13 other studies available for taurine and Bacterial Disease
| Article | Year |
|---|---|
Infection trains the host for microbiota-enhanced resistance to pathogens.
Topics: Animals; Bacterial Infections; Colony Count, Microbial; Gastrointestinal Microbiome; Host-Pathogen I | 2021 |
[Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection].
Topics: Adult; Aged; Anti-Infective Agents; Bacteremia; Bacterial Infections; Catheters, Indwelling; Device | 2009 |
[Local chemotherapy of bone infections with Taurolin].
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Humans; Jaw Diseases; Osteomyelitis; Taurine; Th | 1984 |
Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery.
Topics: Anti-Infective Agents, Local; Bacterial Infections; Colon; Elective Surgical Procedures; Humans; Per | 1995 |
[Initial clinical experience with taurolidin instillation into the area of the middle area].
Topics: Adult; Anti-Infective Agents, Local; Audiometry, Pure-Tone; Bacterial Infections; Female; Follow-Up | 1994 |
The antimicrobial actions of taurolin and other preparations on the pathogenic spectrum in dentoalveolar infections.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Adhesion; Bacterial Infections; Chlorhexidine; Chlortetra | 1993 |
[Use of taurolin in the prevention of septic complications in emergency abdominal surgery].
Topics: Abdomen; Anti-Infective Agents; Bacterial Infections; Emergencies; Humans; Intraoperative Care; Peri | 1991 |
[1996 pathogen incidence and resistance status in peritonitis].
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Humans; Microbial Sensitivi | 1997 |
[The influence of taurolidine on physiological and pathological blood coagulation and implications for its use].
Topics: Anti-Infective Agents, Local; Bacterial Infections; Blood Coagulation; Gram-Negative Bacteria; Gram- | 1999 |
Antimicrobial activity of a novel catheter lock solution.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacterial Infections; Biofilms; Catheterizat | 2002 |
The in vitro and in vivo activity of taurolin against anaerobic pathogenic organisms.
Topics: Animals; Bacterial Infections; Bacteroides; Bacteroides Infections; Clostridium Infections; Clostrid | 1977 |
[The effect of taurolin on endogenous immunity and pathogen elimination in human peritonitis].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents, Local; Bacterial Infections; Colony Count, Microbial | 1992 |
[Treatment of post-traumatic osteomyelitis with Taurolin Gel].
Topics: Administration, Topical; Adult; Arm Injuries; Bacterial Infections; Fracture Fixation, Internal; Fra | 1987 |